Ignite Creation Date:
2024-05-06 @ 9:00 AM
Last Modification Date:
2024-10-26 @ 12:08 PM
Study NCT ID:
NCT02877628
Status:
COMPLETED
Last Update Posted:
2019-01-28
First Post:
2016-08-16
Brief Title:
Immunosuppressive Therapy Optimization Development of a Population Pharmacokinetic-pharmacodynamic PK-PD Model in Liver Transplantation
Sponsor:
Rennes University Hospital
Organization:
Rennes University Hospital
Study Overview
Official Title:
Immunosuppressive Therapy Optimization Development of a Population Pharmacokinetic-pharmacodynamic PK-PD Model in Liver Transplantation
Status:
COMPLETED
Status Verified Date:
2019-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
OPTILTH
Brief Summary:
Prospective non-randomized open Pharmacokinetic-Pharmacogenetic-Pharmacodynamic monocentric study Donor and recipient CYP3A5 genotype and recipient ABCB1 will not be communicate to clinicians or patients during the study
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None